Re: Too much medicine; too little care
Another dpp4 inhibitor or gliptin news bit:
(from medscape article http://www.medscape.com/viewarticle/811716)
"Not only do diabetologists, along with cardiologists, need to take heart failure seriously in patients with diabetes, but the regulators do as well," Dr John J McMurray (University of Glasgow, Scotland) urged the audience. "We need to make heart failure a much more prominent component of our clinical trials, and we must not see major journals publishing major CV-outcomes trials in diabetes and not even mentioning one of the most important — if not the most important — cardiovascular complication of diabetes, which is heart failure."
and my meme.
Competing interests: No competing interests